Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 14 | 390 | 66 | 339 | 139 |
| Gross Profit | 14 | 390 | 66 | 339 | 139 |
| Operating Expenses | 95,986 | 79,664 | 78,902 | 86,245 | 86,403 |
| Operating Income | -95,972 | -79,274 | -78,836 | -85,906 | -86,264 |
| Interest Expense | 8,491 | 4,490 | 3,614 | 3,577 | 3,168 |
| Other Income | 1,465 | -7,788 | -5,979 | 100 | 8,957 |
| Pre-tax Income | -102,998 | -91,552 | -88,429 | -89,383 | -80,475 |
| Income Tax | N/A | 1 | N/A | 2 | 6 |
| Net Income Continuous | -102,998 | -91,553 | -88,429 | -89,385 | -80,481 |
| Minority Interests | -172 | -294 | -800 | -1,097 | -867 |
| Net Income | $-102,826 | $-91,259 | $-87,629 | $-88,288 | $-79,614 |
| EPS Basic Total Ops | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
| EPS Basic Continuous Ops | -0.26 | -0.23 | -0.23 | -0.23 | -0.21 |
| EPS Diluted Total Ops | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
| EPS Diluted Continuous Ops | -0.26 | -0.23 | -0.23 | -0.23 | -0.21 |
| EBITDA(a) | $-91,512 | $-75,475 | $-75,136 | $-81,674 | $-83,292 |